|
It was reported thrombosis occurred.A left atrial appendage closure (laac) procedure was being performed.A watchman fxd double curve access system (was) and a 24mm watchman flx pro laa closure device and delivery system (wds) was selected for use.Transseptal puncture was successfully completed, and the activated clotting time (act) was 373 seconds.The was was inserted, and a 24mm wds was advanced and deployed.After assessment, the 24mm wds was determined to be undersized.The device was recaptured, removed, and exchanged for a larger 27mm wds.As the 27 mm wds was introduced through the was, transesophageal echocardiography (tee) revealed a long, fibrous clot within the left atrial appendage.The 27mm wds was removed from the sheath, and the physician aspirated 30ml of blood through the was.Following aspiration, the clot was no longer visualized on tee; however, no clot was identified in the aspirated blood.The physician then reintroduced and began advancing the same wds.As the device approached the tip of the was sheath, the same fibrous clot was again observed on tee.The device was removed, and aspiration was repeated, this time with 50ml of blood.The clot again disappeared from tee but was not identified in the aspirated blood.It was suspected that the clot was attached to the tip of the sheath, so the was was removed and replaced with a new was, and a new wds was selected.Despite these measures, the same fibrous clot was again visualized on tee.Given the recurrent appearance of the clot and in the interest of patient safety, the procedure was aborted.The plan is to reattempt the procedure in approximately two months.The patient was discharged the next day.
|